PROCEPT BioRobotics Corporation (PRCT)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in PROCEPT BioRobotics Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

PROCEPT BioRobotics Corporation (PRCT) has returned -20.50% so far this year and -57.07% over the past 12 months.

Based on dividend-adjusted daily data since Sep 15, 2021, PRCT's average daily return is +0.04%, while the average monthly return is +0.14%. At this rate, your investment would double in approximately 41.3 years.

Historically, 47% of months were positive and 53% were negative. The best month was Mar 2022 with a return of +40.1%, while the worst month was Jan 2022 at -25.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.

On a daily basis, PRCT closed higher 48% of trading days. The best single day was Oct 28, 2024 with a return of +32.3%, while the worst single day was Apr 27, 2023 at -25.3%.

PROCEPT BioRobotics Corporation has an annualized alpha of -3.15%, beta of 1.27, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since September 16, 2021.

• This stock participated in 129.54% of S&P 500 Index downside but only 50.46% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PRCT ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the PROCEPT BioRobotics Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the PROCEPT BioRobotics Corporation was 77.18%, occurring on Feb 27, 2026. The portfolio has not yet recovered.

The current PROCEPT BioRobotics Corporation drawdown is 74.85%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of PROCEPT BioRobotics Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how PROCEPT BioRobotics Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.